China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A clinical study of cerebral white matter high signaling and vascular-neurodegenerative interactions in Alzheimer's disease based on multimodal analysis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135478
Registration Time: 2026/10/30
Type: Observational study
Primary Sponsor: Zhengzhou Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=283616
Published by HT Digital Content Services with permission from Health Daily Digest....